Steven K. Grinspoon, MD, on the Effects of Tesamorelin on NAFLD in Patients With HIV
11/26/2019
In this podcast, Steven Grinspoon, MD, discusses his latest research on the effects of tesamorelin use on non-alcoholic fatty liver disease (NAFLD) in patients with HIV, how the increase in obesity among patients with HIV affects the risk for NAFLD, and more.
Steven K. Grinspoon, MD, is a professor of medicine and director of the Nutrition Obesity Research Center at Harvard Medical School in Boston, Massachusetts. He is also the chief of the Metabolism Unit and the MGH Endowed Chair in Neuroendocrinology and Metabolism at Massachusetts General Hospital in Boston, Massachusetts.
Additional Reading:
- Stanley TL, Fourman LT, Feldpausch MN, et al. Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial [published online October 29, 2019]. Lancet HIV. https://doi.org/10.1016/S2352-3018(19)30338-8.